[1] SESHADRI S，BEISER A，PIKULA A，et al.

Parental occurrence of stroke and risk of stroke in

their children：the Framingham study[J]. Circulation，

2010，121（11）：1304-1312.

[2] GRETARSDOTTIR S，THORLEIFSSON G，

MANOLESCU A，et al. Risk variants for atrial

fibrillation on chromosome 4q25 associate with

ischemic stroke[J]. Ann Neurol，2008，64（4）：402-

409.

[3] 孙一忞，吴志英. CADASIL患者的临床、影像和

Notch3基因突变特点及我国研究现状[J]. 中国卒中

杂志，2012，7（2）：136-140.

[4] FUKUTAKE T. Cerebral autosomal recessive

arteriopathy with subcortical infarcts and

leukoencephalopathy（CARASIL）：from discovery

to gene identification[J]. J Stroke Cerebrovasc Dis，

2011，20（2）：85-93.

[5] LAWRENCE C，WEBB J. Sickle Cell Disease and

Stroke：Diagnosis and Management[J]. Curr Neurol

Neurosci Rep，2016，16（3）：27.

[6] TALAHMA M，STRBIAN D，SUNDARARAJAN

S. Sickle cell disease and stroke[J/OL]. Stroke，

2014，45（6）：e98-100. http：//doi.org/10.1161/

STROKEAHA.114.005144.

[7] RUSSELL M O，GOLDBERG H I，HODSON A，et

al. Effect of transfusion therapy on arteriographic

abnormalities and on recurrence of stroke in sickle

cell disease[J]. Blood，1984，63（1）：162-169.

[8] SCHATZ J，BROWN R T，PASCUAL J M，et al.

Poor school and cognitive functioning with silent

cerebral infarcts and sickle cell disease[J]. Neurology，

2001，56（8）：1109-1111.

[9] YUASA T，TAKENAKA T，HIGUCHI K，et al.

Fabry disease[J]. J Echocardiogr，2017，15（4）：151-

157.

[10] MEHTA A，GINSBERG L，FOS INVESTIGATORS.

Natural history of the cerebrovascular complications

of Fabry disease[J]. Acta Paediatr Suppl，2005，94

（447）：24-27.

[11] LIDOVE O，WEST ML，PINTOS-MORELL G，et

al. Effects of enzyme replacement therapy in Fabry

disease--a comprehensive review of the medical

literature[J]. Genet Med，2010，12（11）：668-679.

[12] KUO D S，LABELLE-DUMAIS C，GOULD D

B. COL4A1 and COL4A2 mutations and disease：

insights into pathogenic mechanisms and potential

therapeutic targets[J/OL]. Hum Mol Genet，2012，21

（R1）：R97-110. https：//doi.org/10.1093/hmg/dds346.

[13] GOULD D B，PHALAN F C，VAN MIL S E，et

al. Role of COL4A1 in small-vessel disease and

hemorrhagic stroke[J]. N Engl J Med，2006，354

（14）：1489-1496.

[14] LANFRANCONI S，MARKUS H S. COL4A1

mutations as a monogenic cause of cerebral small

vessel disease：a systematic review[J/OL]. Stroke，

2010，41（8）：e513-518. http：//doi.org/10.1161/

STROKEAHA.110.581918.

[15] ALAMOWITCH S，PLAISIER E，FAVROLE P，

et al. Cerebrovascular disease related to COL4A1

mutations in HANAC syndrome[J]. Neurology，2009，73（22）：1873-1882.

[16] MCCULLY K S. Vascular pathology of

homocysteinemia：implications for the pathogenesis

of arteriosclerosis[J]. Am J Pathol，1969，56（1）：

111-128.

[17] GUNGOR L，POLAT M，OZBERK M B，et al.

Which Ischemic Stroke Subtype Is Associated with

Hyperhomocysteinemia?[J]. J Stroke Cerebrovasc

Dis，2018，27（7）：1921-1929.

[18] WU G H，KONG F Z，DONG X F，et al. Association

between hyperhomocysteinemia and stroke with

atherosclerosis and small artery occlusion depends

on homocysteine metabolism-related vitamin levels

in Chinese patients with normal renal function[J].

Metab Brain Dis，2017，32（3）：859-865.

[19] HOLLIDAY E G，TRAYLOR M，MALIK R，et

al. Genetic overlap between diagnostic subtypes of

ischemic stroke[J]. Stroke，2015，46（3）：615-619.

[20] TRAYLOR M，FARRALL M，HOLLIDAY E G，et

al. Genetic risk factors for ischaemic stroke and its

subtypes（the METASTROKE collaboration）：a

meta-analysis of genome-wide association study[J].

Lancet Neurol，2012，11（11）：951-962.

[21] WILLIAMS F M，CARTER A M，HYSI P G，et

al. Ischemic stroke is associated with the ABO locus：

the EuroCLOT study[J]. Ann Neurol，2013，73（1）：

16-31.

[22] SCHILLING S，DESTEFANO A L，SACHDEV

P S，et al. APOE genotype and MRI markers of

cerebrovascular disease：systematic review and

meta-analysis[J]. Neurology，2013，81（3）：292-300.

[23] ILINCA A，SAMUELSSON S，PICCINELLI

P，et al. A stroke gene panel for whole-exome

sequencing[J]. Eur J Hum Genet，2018，27（2）：317-

324.